Detalles de la búsqueda
1.
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Int J Cancer
; 153(7): 1413-1422, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37424386
2.
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations.
Br J Cancer
; 129(3): 475-485, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365284
3.
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
BMC Cancer
; 21(1): 932, 2021 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407800
4.
Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers.
Med J Aust
; 209(8): 354-355, 2018 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30138578
5.
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.
BMC Cancer
; 16: 339, 2016 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27246726
6.
Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensing.
Nat Commun
; 15(1): 1818, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443394
7.
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumab.
Mol Oncol
; 17(2): 298-311, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426653
8.
The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey.
Oncotarget
; 12(21): 2169-2176, 2021 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34676049
9.
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology.
NPJ Precis Oncol
; 5(1): 58, 2021 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34162978
10.
Author Correction: Therapeutic implications of germline genetic findings in cancer.
Nat Rev Clin Oncol
; 16(6): 397, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996255
11.
Therapeutic implications of germline genetic findings in cancer.
Nat Rev Clin Oncol
; 16(6): 386-396, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30783251
12.
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.
Clin Colorectal Cancer
; 17(4): 313-319, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30463680
13.
Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysis.
Expert Rev Anticancer Ther
; 17(10): 965-979, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28819989
14.
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion.
JCO Precis Oncol
; 6: e2200263, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455193
15.
Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on management.
J Neurol Sci
; 438: 120291, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35635863
16.
Optimal therapy for resectable rectal cancer.
Expert Rev Anticancer Ther
; 16(3): 285-302, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26652907
17.
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.
Expert Rev Anticancer Ther
; 16(5): 557-71, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27010906
18.
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.
J Clin Oncol
; 34(19): 2258-64, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114605
Resultados
1 -
18
de 18
1
Próxima >
>>